Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|March 23, 2012
Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trialJames J DiNicolantonioExpert Opinion on Pharmacotherapy|March 20, 2012
Hydrochlorothiazide: is it a wise choice?James J DiNicolantonioExpert Review of Cardiovascular Therapy|November 30, 2012
CoQ10 and L-carnitine for statin myalgia?James J DiNicolantonioFuture Cardiology|September 28, 2012
Should torsemide be the loop diuretic of choice in systolic heart failure?James J DiNicolantonioMissouri Medicine|December 14, 2020
The Importance of Maintaining a Low Omega-6/Omega-3 Ratio for Reducing the Risk of Inflammatory Cytokine StormsJames J DiNicolantonio, James O'KeefeOpen Heart|October 22, 2014
Hypertension: empirical evidence and implications in 2014Spyros Makridakis, James J DiNicolantonioOpen Heart|August 23, 2016
Added sugars drive nutrient and energy deficit in obesity: a new paradigmJames J DiNicolantonio, Amy BergerInternational Journal of Cardiology|October 15, 2013
Misrepresentation of vital status follow-up: challenging the integrity of the PLATO trial and the claimed mortality benefit of ticagrelor versus clopidogrelJames J DiNicolantonio, Ales TomekInternational Journal of Cardiology|August 6, 2013
Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trialJames J DiNicolantonio, Ales TomekOpen Heart|June 14, 2020
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidaseJames J DiNicolantonio, Mark McCartyPageof 16